71390-125Level 3
Barhemsys (Amisulpride)
**Product type:** Human Prescription Drug
**Active ingredient:** AMISULPRIDE
**Strength:** 2.5 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Acacia Pharma Ltd
**Marketing category:** NDA (NDA209510)
**Pharmacologic class:** Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/71390-125Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.